Evidence map›Paper›PMID 19765273›Full record

ArticleBMC immunology2009

Ethanol inhibits LPS-induced signaling and modulates cytokine production in peritoneal macrophages in vivo in a model for binge drinking.

Stephen B Pruett, Ruping Fan

Open access · goldAbstract read
In one paragraph

Article in BMC immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Innate Immunity and Alcohol.Journal of clinical medicine · 2019
    Review
  3. Alcohol, aging, and innate immunity.Journal of leukocyte biology · 2017
    Review
  4. Microbiota-based treatments in alcoholic liver disease.World journal of gastroenterology · 2016
    Review
  5. Review
  6. β-Arrestin 2 mediates the anti-inflammatory effects of fluoxetine in lipopolysaccharide-stimulated microglial cells.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2014
    Article
  7. Article
  8. Article
  9. Binge ethanol and liver: new molecular developments.Alcoholism, clinical and experimental research · 2013
    Review
  10. Article
  11. Article
  12. Article
  13. Nicotine: alcohol reward interactions.Neurochemical research · 2010
    Review
  14. Alcoholic liver disease and the gut-liver axis.World journal of gastroenterology · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Stephen B PruettDepartment of Cellular Biology and Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA. Pruett@cvm.msstate.edu
Ruping Fan
Louisiana State University Health Sciences Center Shreveport · US

Funding

MECHANISMS OF IMMUNOSUPPRESSION BY ONE DOSE OF ETHANOLR01AA009505 · NIAAA · MISSISSIPPI STATE UNIVERSITY · PI PRUETT, STEPHEN B · 1994 to 2007
$1.5M
NIAAA NIH HHS R01 AA 009505NIAAA NIH HHS R01 AA009505
6 · The paper itself

Abstract

backgroundPrevious reports indicate that ethanol, in a binge drinking model in mice, inhibits the production of pro-inflammatory cytokines in vivo. However, the inhibition of signaling through TLR4 has not been investigated in this experimental model in vivo. Considering evidence that signaling can be very different in vitro and in vivo, the present study was conducted to determine if effects of ethanol on TLR4 signaling reported for cells in culture or cells removed from ethanol treated mice and stimulated in culture also occur when ethanol treatment and TLR4 activation occur in vivo.

resultsPhosphorylated p38, ERK, and c-Jun (nuclear) were quantified with kits or by western blot using samples taken 15, 30, and 60 min after stimulation of peritoneal macrophages with lipopolysaccharide in vivo. Effects of ethanol were assessed by administering ethanol by gavage at 6 g/kg 30 min before administration of lipopolysaccharide (LPS). Cytokine concentrations in the samples of peritoneal lavage fluid and in serum were determined at 1, 2, and 6 hr after lipopolysaccharide administration. All of these data were used to measure the area under the concentration vs time curve, which provided an indication of the overall effects of ethanol in this system. Ethanol suppressed production of most pro-inflammatory cytokines to a similar degree as it inhibited key TLR4 signaling events. However, NF-kappaB (p65) translocation to the nucleus was not inhibited by ethanol. To determine if NF-kappaB composed of other subunits was inhibited, transgenic mice with a luciferase reporter were used. This revealed a reproducible inhibition of NF-kappaB activity, which is consistent with the observed inhibition of cytokines whose expression is known to be NF-kappaB dependent.

conclusionOverall, the effects of ethanol on signalling in vivo were similar to those reported for in vitro exposure to ethanol and/or lipopolysaccharide. However, inhibition of the activation of NF-kappaB was not detected as translocation of p65 to the nucleus but was detected using transgenic reporter mice. The observation that ethanol given 24 hr before dosing with LPS modulated production of some cytokines indicates a persistent effect which does not require continued presence of ethanol.

Indexed as

AnimalsCells, CulturedCytokinesDisease Models, AnimalEthanolFemaleImmunomodulationLipopolysaccharidesMacrophages, PeritonealMiceMice, Inbred C3HMice, Inbred C57BLMice, TransgenicNF-kappa BSignal TransductionToll-Like Receptor 4CytokinesEthanolLipopolysaccharidesNF-kappa BToll-Like Receptor 4

Identifiers

PMID19765273
PMCPMC2761873
OpenAlexW2006239294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.